Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

CSL receives positive results from rare disease drug phase 3 trial

February 28, 2023 Research and Development

Biotech company CSL has reported positive results from its phase 3 trial for garadacimab, a monthly treatment for hereditary angioedema …
News

BiomX shares positive data from first bacteriophage trial

February 23, 2023 Research and Development

BiomX has shared data from a new study in cystic fibrosis (CF) patients, assessing whether bacteriophages could be a new …
News

Redx Pharma agrees to $425m all-share merger with Jounce Therapeutics

February 23, 2023 Research and Development

UK-based clinical-stage biotech company Redx Pharma has agreed to a $425m all-share merger with US drug research business Jounce Therapeutics. …
News

Karyopharm and Menarini gain full MHRA approval for multiple myeloma drug

February 22, 2023 Research and Development

Pharmaceutical companies Karyopharm Therapeutics and Menarini Group have announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) have …
News

FDA grants approval to Beckley Psytech’s short-acting psychedelic trial

February 22, 2023 Research and Development

Beckley Psytech, a private, clinical-stage biotech company, announced that the FDA has granted Investigational New Drug (IND) approval for their …
News

Pfizer likely to be first to gain FDA approval for new RSV vaccine

February 22, 2023 Research and Development

The FDA is expected to approve Pfizer’s new respiratory syncytial virus (RSV) vaccine this summer following its acceptance of the …
News

Hemab secures $135m in Series B funding for rare bleeding disorder treatment

February 21, 2023 Research and Development

Hemab Therapeutics announced it received $135m from their oversubscribed Series B funding round. The funding will be used for their …
News

Scancell shares encouraging results from phase 1/2 cancer trial

February 21, 2023 Research and Development

Scancell Holdings PLC have shared early results from its phase 1/2 cancer study which appear “very encouraging”, according to one …
News

Scancell shares “highly encouraging” results from phase 1 COVID-19 vaccine trial

February 13, 2023 Research and Development

Scancell Holdings PLC has shared “highly encouraging” results from its phase 1 clinical trial of its COVID-19 vaccines, says chief …
News

SynaptixBio secures FDA Rare Paediatric Disease designation to develop treatments for TUBB4a leukodystrophy

February 10, 2023 Research and Development

SynaptixBio, a UK-based biotech firm, has been granted FDA Rare Paediatric Disease (RPD) designation – an accolade which encourages the …
News

FDA approves Regeneron’s Eylea for the treatment of retinopathy of prematurity in infants

February 9, 2023 Research and Development

The FDA has approved Regeneron Pharmaceuticals’ Eylea (aflibercept) injection for the treatment of retinopathy of prematurity (ROP) in preterm infants. …
News

Johnson & Johnson’s Ethicon undertakes first robot-assisted kidney stone removal

February 8, 2023 Research and Development

Johnson & Johnson (J&J) medtech company, Ethicon, has announced its first robotic-assisted kidney stone removal using its Monarch platform. The …
News

Sandoz files Amgen biosimilar drug for osteoporosis

February 8, 2023 Research and Development

Switzerland-based Sandoz has filed a proposed biosimilar of Amgen’s osteoporosis drug Prolia/Xgeva with the FDA. According to Sandoz, over 10 …
News

4D Molecular Therapeutics’ Fabry Gene Therapy put on FDA-mandated hold

February 7, 2023 Research and Development

4D Molecular Therapeutics has had its gene therapy programme 4D-310 put on clinical hold by the FDA after adverse side …
News

SPR Therapeutics gains FDA extended approval for pain management system

February 6, 2023 Research and Development

Pain management medical device company SPR Therapeutics has obtained expanded approval from the FDA for its SPRINT Peripheral Nerve System …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026